RCUS Arcus Biosciences, Inc. Common Stock
NYSE · Biotechnology · Auf SEC EDGAR ansehen ↗ Schließen Okt 2, 2026 10-K/10-Q Aug 5, 2026
$24,44
· % der 52-Wochen-Spanne
· über Tiefststand
· zu hoch
$13,2152-Wochen-Tief
$31,7452-Wochen-Hoch
Marktkapitalisierung (MRQ)
$3.10B
P/E (TTM)
-6.3
EPS (TTM)
$-3.89
Umsatz (TTM)
$117M
Ihre Abzeichen
52W-Spanne
$13–$32
Analystenbewertung
BUY
Kursziel
$40
P/E
-6.3
ROE
-90.8%
Nettogewinnmarge
-393.2%
Ihre Abzeichenleiste ist leer – heften Sie eine Kennzahl auf dieser Seite an.
RCUS Aktien-Snapshot Kurs, Marktkapitalisierung, P/E, EPS, ROE, Schulden/Eigenkapital, 52-Wochen-Spanne
Kurs
$24.44
Marktkapitalisierung (MRQ)
$3.10B
P/E (TTM)
-6.3
EPS (TTM)
$-3.89
Umsatz (TTM)
$117M
ROE (TTM)
-90.8%
52W-Spanne
$13–$32
RCUS Aktienkurs-Chart Täglich OHLCV mit technischen Indikatoren — Schwenken, Zoom und Ansicht anpassen
Spanne
Balken
Die Balkengranularität passt sich der ausgewählten Periode an – bewegen Sie den Mauszeiger über das Diagramm, um Eröffnungs-/Höchst-/Tiefst-/Schlusskurse für einen Balken anzuzeigen.
Über Arcus Biosciences, Inc. Common Stock Unternehmensübersicht von Wikipedia
SektorHealthcare
BrancheBiotechnology
Mitarbeiter601
LandUS
10-Jahres-Performance Umsatz-, Nettoergebnis-, Margen- und EPS-Trends
Umsatz$247M2017-12-31 → 2025-12-31
EPS$-3.292019-12-31 → 2025-12-31
Freier Cashflow$-484M2018-12-31 → 2025-12-31
Nettogewinnmarge-393.2%2018-12-31 → 2025-12-31
Bewertung & Kennzahlen
Bewertung P/E-, P/S-, P/B-, EV/EBITDA-Verhältnisse — ist die Aktie teuer oder günstig?
| Kennzahl | 5-Jahres-Trend | RCUS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| P/E (TTM) | -6.35-Jahres-Durchschnitt ≈7.0 | ≈7.0 | · | · | |
| P/S (TTM) | 26.55-Jahres-Durchschnitt ≈10.1 | ≈10.1 | 28.1 | Teurer | |
| K/B (MRQ) | 6.75-Jahres-Durchschnitt ≈3.3 | ≈3.3 | 4.9 | Überbewertet | |
| Kurs / FCF (TTM) | -6.55-Jahres-Durchschnitt ≈-5.0 | ≈-5.0 | · | · | |
| Kurs / Cashflow (TTM) | -6.55-Jahres-Durchschnitt ≈-5.3 | ≈-5.3 | · | · | |
| Price / Tangible Book (Kurs / Materieller Buchwert) | 4.95-Jahres-Durchschnitt ≈3.3 | ≈3.3 | · | · |
Der Median der Vergleichsgruppe wird pro Kennzahl standardisiert berechnet und stimmt möglicherweise nicht immer mit der für diese Aktie angezeigten TTM/MRQ-Basis überein.
Rentabilität Brutto-, Betriebs- und Nettomargen; ROE, ROA, ROIC
| Kennzahl | 5-Jahres-Trend | RCUS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Betriebsgewinnmarge (TTM) | -415.4%5-Jahres-Durchschnitt ≈-162.1% | ≈-162.1% | 12.5% | Schwach | |
| EBITDA Margin (EBITDA-Marge) | -156.3%5-Jahres-Durchschnitt ≈-162.1% | ≈-162.1% | 12.5% | Schwach | |
| Vorgewinnmarge (TTM) | -393.2%5-Jahres-Durchschnitt ≈-146.5% | ≈-146.5% | 25.8% | Schwach | |
| Nettogewinnmarge (TTM) | -393.2%5-Jahres-Durchschnitt ≈-147.9% | ≈-147.9% | 10.9% | Schwach | |
| ROA (TTM) | -46.0%5-Jahres-Durchschnitt ≈-19.0% | ≈-19.0% | -6.2% | Schwach | |
| ROE (TTM) | -90.8%5-Jahres-Durchschnitt ≈-41.6% | ≈-41.6% | -7.0% | Schwach | |
| ROIC | -61.2%5-Jahres-Durchschnitt ≈-48.2% | ≈-48.2% | -20.6% | Schwach |
Finanzielle Gesundheit Verschuldung, Liquidität, Solvenz — Bilanzstärke
| Kennzahl | 5-Jahres-Trend | RCUS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Liquiditätsgrad (MRQ) | 3.85-Jahres-Durchschnitt ≈5.3 | ≈5.3 | 4.6 | Geringe Liquidität | |
| Quick Ratio | 1.05-Jahres-Durchschnitt ≈0.9 | ≈0.9 | 4.4 | Geringe Liquidität |
Wachstum Umsatz-, EPS- und Nettoergebniswachstum: YoY, 3-Jahres-CAGR, 5-Jahres-CAGR
| Kennzahl | 5-Jahres-Trend | RCUS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Revenue YoY (Umsatz YoY) | -4.3%5-Jahres-Durchschnitt ≈88.2% | ≈88.2% | · | · | |
| Revenue CAGR 3Y (Umsatz CAGR 3J) | 30.2%5-Jahres-Durchschnitt ≈10.8% | ≈10.8% | · | · | |
| Revenue CAGR 5Y (Umsatz CAGR 5J) | 25.9% | · | · | · |
Kapitaleffizienz Umsatz pro Vermögenswert, Lagerumschlag, Forderungsumschlag
| Kennzahl | 5-Jahres-Trend | RCUS | 5-Jahres-Durchschnitt | Peer-Median | Fazit |
|---|---|---|---|---|---|
| Asset Turnover (Umsatz / Vermögenswerte) | 0.25-Jahres-Durchschnitt ≈0.2 | ≈0.2 | 0.2 | Spitzenklasse | |
| Revenue / Employee (Umsatz / Mitarbeiter) | ≈$411.0K | · | · | · |
Wert · ≈ 5-Jahres-Durchschnitt · Branchenmedian · Urteil relativ zum Median
Ergebnisverlauf EPS Ist vs. Schätzung, Überraschung %, Beat-Rate, nächstes Ergebnisdatum
Durchschn. Überraschung
19.8%
Nächster Bericht
Okt 26, 2026
| Zeitraum | Bericht | EPS Actual | EPS est. | Überraschung |
|---|---|---|---|---|
| 30. Juni 2026 | Aug 12, 2026 | $-0.72 | $-0.92 | 21.4% |
| 31. März 2026 | Mai 12, 2026 | $-1.02 | $-0.89 | -14.0% |
| 31. Dezember 2025 | $-0.89 | $-1.05 | 15.0% | |
| 30. September 2025 | $-1.27 | $-1.34 | 5.0% | |
| 30. Juni 2025 | $0.00 | $-1.15 | 100.0% | |
| 31. März 2025 | $-1.14 | $-1.05 | -8.4% |
Vollständige Fundamentaldaten Alle Kennzahlen nach Jahr — Gewinn- und Verlustrechnung, Bilanz, Cashflow
Gewinn- und Verlustrechnung
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $247M | $258M | $117M | $112M | $383M | $78M | $15M | $8M | $1M | |
| R&D Expense | $523M | $448M | $340M | $288M | $257M | $159M | $78M | $50M | $47M | |
| SG&A Expense | $110M | $120M | $117M | $104M | $72M | $43M | $25M | $14M | $8M | |
| Operating Expenses | $633M | $588M | $457M | $392M | $329M | $202M | $104M | $63M | $55M | |
| Operating Income | $-386M | $-330M | $-340M | $-280M | $54M | $-124M | $-89M | $-55M | $-53M | |
| Other Non-op | $33M | $48M | $39M | $14M | $1M | $1M | $4M | $5M | $359.0K | |
| Pretax Income | $-353M | $-282M | $-301M | $-266M | $55M | $-123M | $-85M | · | · | |
| Income Tax | $0 | $1M | $6M | $1M | $2M | · | · | · | · | |
| Net Income | $-353M | $-283M | $-307M | $-267M | $53M | $-123M | $-85M | $-50M | $-53M | |
| EPS (Basic) | $-3.29 | $-3.14 | $-4.15 | $-3.71 | $0.76 | $-2.24 | $-1.93 | · | · | |
| EPS (Diluted) | $-3.29 | $-3.14 | $-4.15 | $-3.71 | $0.71 | $-2.24 | $-1.93 | · | · | |
| Shares (Basic) | 107,400,000 | 90,100,000 | 74,000,000 | 72,000,000 | 69,300,000 | 54,800,000 | 43,825,991 | 36,357,336 | 3,885,508 | |
| Shares (Diluted) | 107,400,000 | 90,100,000 | 74,000,000 | 72,000,000 | 74,000,000 | 54,800,000 | 43,825,991 | · | · | |
| EBITDA | $-386M | $-330M | $-340M | $-280M | $54M | $-124M | $-89M | $-55M | · |
Bilanz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $222M | $150M | $127M | $206M | $148M | $173M | $58M | $71M | $98M | |
| Short-term Investments | · | · | · | · | · | $555M | $130M | $185M | $77M | |
| Prepaid Expense | $15M | $18M | $34M | $19M | $18M | $5M | $4M | $2M | $1M | |
| Current Assets | $1.01B | $1.02B | $831M | $1.07B | $1.26B | $736M | $193M | $259M | $177M | |
| PP&E (Net) | $40M | $47M | $51M | $35M | $32M | $11M | $9M | $11M | $11M | |
| PP&E (Gross) | $90M | $88M | $82M | $58M | $50M | $25M | $21M | $19M | $15M | |
| Accum. Depreciation | $50M | $41M | $31M | $23M | $18M | $14M | $11M | $8M | $4M | |
| Other Non-current Assets | $63M | $73M | $106M | $114M | $116M | $6M | $872.0K | $284.0K | $2M | |
| Total Assets | $1.14B | $1.15B | $1.09B | $1.34B | $1.59B | $772M | $203M | $275M | $190M | |
| Accounts Payable | $42M | $18M | $17M | $20M | $10M | $16M | $5M | $3M | $4M | |
| Accrued Liabilities | · | · | · | · | $24M | $10M | $5M | $6M | $3M | |
| Current Liabilities | $231M | $226M | $184M | $193M | $166M | $122M | $23M | $17M | $13M | |
| Capital Leases | $86M | $99M | $110M | $117M | $117M | $15M | · | · | · | |
| Other Non-current Liabilities | $135M | $157M | $142M | $140M | $122M | $543.0K | $806.0K | $2M | $565.0K | |
| Total Liabilities | · | · | · | · | $750M | $270M | $39M | $40M | $37M | |
| Long-term Debt | $99M | $48M | $0 | · | · | · | · | · | · | |
| Common Stock | $2.12B | $1.62B | $1.31B | $1.21B | $1.12B | $6.0K | $4.0K | $4.0K | · | |
| Paid-in Capital | · | · | · | · | $1.12B | $830M | $369M | $358M | $948.0K | |
| Retained Earnings | $-1.49B | $-1.13B | $-849M | $-542M | $-275M | $-328M | $-205M | $-123M | $-73M | |
| AOCI | $0 | · | $0 | $-7M | $-1M | $44.0K | $64.0K | $-107.0K | $-42.0K | |
| Stockholders' Equity | $631M | $485M | $462M | $657M | $842M | $502M | $164M | $235M | $-72M | |
| Liabilities + Equity | $1.14B | $1.15B | $1.09B | $1.34B | $1.59B | $772M | $203M | $275M | $190M | |
| Shares Outstanding | 125,300,000 | 92,200,000 | 75,500,000 | 72,900,000 | 70,800,000 | 63,700,000 | 44,200,000 | 43,610,823 | 3,278,129 |
Cashflow
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $10M | $10M | $8M | $6M | $4M | $3M | $4M | $4M | $3M | |
| Stock-based Comp | $60M | $76M | $73M | $65M | $55M | $22M | $9M | $4M | $495.0K | |
| Operating Cash Flow | $-482M | $-170M | $-306M | $438M | $-256M | $111M | $-73M | $-43M | $-25M | |
| CapEx | $2M | $6M | $24M | $6M | $26M | $3M | $2M | $4M | $6M | |
| Investing Cash Flow | $66M | $-84M | $194M | $-413M | $-4M | $-434M | $59M | $-113M | $-49M | |
| Stock Issued | $429M | $228M | $25M | $0 | $220M | $434M | $1M | $4M | · | |
| Stock Repurchased | · | · | · | · | · | · | $94.0K | $0 | · | |
| Net Stock Activity | $429M | $228M | $25M | · | $220M | $434M | $1M | · | · | |
| Financing Cash Flow | $488M | $277M | $33M | $33M | $237M | $439M | $1M | $129M | $107M | |
| Net Change in Cash | $72M | $23M | $-79M | $58M | $-23M | $116M | $-13M | $-27M | $33M | |
| Taxes Paid | $0 | $0 | $5M | · | · | · | · | · | · | |
| Free Cash Flow | $-484M | $-176M | $-330M | $432M | $-282M | $108M | $-75M | $-47M | · |
Rentabilität
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -156.3% | -127.9% | -290.6% | -250.0% | 14.2% | · | -591.4% | -656.8% | · | |
| Net Margin | -142.9% | -109.7% | -262.4% | -238.4% | 13.8% | · | -564.7% | -593.7% | · | |
| Pretax Margin | -142.9% | -109.3% | -257.3% | -237.5% | 14.3% | · | · | · | · | |
| EBITDA Margin | -156.3% | -127.9% | -290.6% | -250.0% | 14.2% | · | -591.4% | -656.8% | · | |
| ROA | -30.8% | -25.2% | -25.2% | -18.2% | 4.5% | -25.2% | -35.4% | -21.3% | · | |
| ROE | -59.8% | -53.9% | -62.5% | -39.4% | 7.6% | -23.5% | -49.7% | -20.7% | · | |
| ROIC | -61.2% | -68.3% | -75.1% | -42.8% | 6.2% | · | · | · | · |
Liquidität & Solvenz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 4.4 | 4.5 | 4.5 | 5.5 | 7.6 | 6.0 | 8.5 | 15.3 | · | |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 1.1 | 0.9 | 6.0 | 8.3 | 15.1 | · |
Effizienz
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.2 | 0.2 | 0.1 | 0.1 | 0.3 | · | 0.1 | 0.0 | · |
Pro Aktie
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $5.04 | $5.26 | $6.12 | $9.01 | $11.89 | $7.71 | $3.57 | $5.28 | · | |
| Revenue / Share | $2.30 | $2.86 | $1.58 | $1.56 | $5.18 | · | · | · | · | |
| Cash Flow / Share | $-4.49 | $-1.89 | $-4.14 | $6.08 | $-3.46 | · | · | · | · | |
| Cash / Share | $1.77 | $1.63 | $1.68 | $2.83 | $2.09 | $2.66 | $1.26 | $1.60 | · | |
| EPS (TTM) | $-3.29 | $-3.14 | $-4.15 | $-3.71 | $0.71 | $-2.24 | $-1.93 | · | · |
Wachstumsraten
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -4.3% | 120.5% | 4.5% | -70.8% | 391.0% | · | · | · | · | |
| Revenue CAGR 3Y | 30.2% | -12.3% | 14.5% | · | · | · | · | · | · | |
| Revenue CAGR 5Y | 25.9% | · | · | · | · | · | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $247M | $258M | $117M | $112M | $383M | $78M | $15M | $8M | · | |
| Net Income TTM | $-353M | $-283M | $-307M | $-267M | $53M | $-123M | $-85M | $-50M | · | |
| Market Cap | $2.99B | $1.37B | $1.44B | $1.51B | $2.86B | $1.69B | $464M | $480M | · | |
| P/E | -7.2 | -4.7 | -4.6 | -5.6 | 57.0 | -11.6 | -5.2 | · | · | |
| P/S | 12.1 | 5.3 | 12.3 | 13.5 | 7.5 | 21.7 | 30.9 | 57.4 | · | |
| P/B | 4.7 | 2.8 | 3.1 | 2.3 | 3.4 | 3.4 | 2.8 | 2.0 | · | |
| P / Tangible Book | 4.7 | 2.8 | 3.1 | 2.3 | 3.4 | 3.4 | · | · | · | |
| P / Cash Flow | -6.2 | -8.1 | -4.7 | 3.4 | -11.2 | 15.2 | -6.3 | -11.2 | · | |
| P / FCF | -6.2 | -7.8 | -4.4 | 3.5 | -10.1 | 15.6 | -6.2 | -10.3 | · | |
| Earnings Yield | -13.8% | -21.1% | -21.7% | -17.9% | 1.8% | -8.6% | -19.1% | · | · |
Gewinn- und Verlustrechnung
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $41M | $17M | $33M | $26M | $160M | $28M | $26M | $48M | $39M | $145M | $31M | $32M | $29M | $25M | $34M | $33M | |
| R&D Expense | $113M | $122M | $121M | $141M | $139M | $122M | $101M | $123M | $115M | $109M | $93M | $82M | $84M | $81M | $80M | $77M | |
| SG&A Expense | $24M | $29M | $26M | $27M | $29M | $28M | $28M | $30M | $30M | $32M | $29M | $30M | $28M | $30M | $28M | $26M | |
| Operating Expenses | $137M | $151M | $147M | $168M | $168M | $150M | $129M | $153M | $145M | $161M | $122M | $112M | $112M | $111M | $108M | $103M | |
| Operating Income | $-96M | $-134M | $-114M | $-142M | $-8M | $-122M | $-103M | $-105M | $-106M | $-16M | $-91M | $-80M | $-83M | $-86M | $-74M | $-70M | |
| Other Non-op | $5M | $6M | $8M | $7M | $8M | $10M | $10M | $13M | $13M | $12M | $11M | $11M | $9M | $8M | $7M | $5M | |
| Pretax Income | $-91M | $-128M | $-106M | $-135M | $0 | $-112M | $-93M | $-92M | $-93M | $-4M | $-80M | $-69M | $-74M | $-78M | $-67M | $-65M | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $1M | $0 | $0 | $0 | $1M | $2M | $1M | $2M | $0 | $0 | |
| Net Income | $-91M | $-128M | $-106M | $-135M | $0 | $-112M | $-94M | $-92M | $-93M | $-4M | $-81M | $-71M | $-75M | $-80M | $-67M | $-65M | |
| EPS (Basic) | $-0.72 | $-1.02 | $-0.88 | $-1.27 | $0.00 | $-1.14 | $-1.07 | $-1.00 | $-1.02 | $-0.05 | $-1.08 | $-0.94 | $-1.04 | $-1.09 | $-0.93 | $-0.90 | |
| EPS (Diluted) | $-0.72 | $-1.02 | $-0.88 | $-1.27 | $0.00 | $-1.14 | $-1.07 | $-1.00 | $-1.02 | $-0.05 | $-1.08 | $-0.94 | $-1.04 | $-1.09 | $-0.93 | $-0.90 | |
| Shares (Basic) | 126,100,000 | 125,400,000 | · | 106,500,000 | 106,100,000 | 98,400,000 | · | 91,400,000 | 91,100,000 | 86,200,000 | · | 74,600,000 | 73,200,000 | 73,000,000 | · | 72,200,000 | |
| Shares (Diluted) | 126,100,000 | 125,400,000 | · | 106,500,000 | 106,500,000 | 98,400,000 | · | 91,400,000 | 91,100,000 | 86,200,000 | · | 74,600,000 | 73,200,000 | 73,000,000 | · | 72,200,000 | |
| EBITDA | $-96M | $-134M | · | $-142M | $-8M | $-122M | · | $-105M | $-106M | $-16M | · | $-80M | $-83M | $-86M | · | $-69M |
Bilanz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $150M | $201M | $222M | $238M | $248M | $192M | $150M | $201M | $156M | $185M | · | $184M | $230M | $238M | · | $218M | |
| Prepaid Expense | $18M | $19M | $15M | $15M | $20M | $19M | $18M | $22M | $25M | $34M | · | $31M | $22M | $28M | · | $22M | |
| Current Assets | $756M | $844M | $1.01B | $857M | $946M | $1.03B | $1.02B | $1.13B | $1.02B | $1.06B | · | $882M | $986M | $1.01B | · | $1.10B | |
| PP&E (Net) | $36M | $38M | $40M | $42M | $44M | $46M | $47M | $48M | $49M | $51M | · | $50M | $45M | $37M | · | $34M | |
| PP&E (Gross) | · | · | $90M | · | · | · | $88M | · | · | · | · | · | · | · | · | · | |
| Accum. Depreciation | · | · | $50M | · | · | · | $41M | · | · | · | · | · | · | · | · | · | |
| Other Non-current Assets | $59M | $61M | $63M | $65M | $69M | $71M | $73M | $75M | $75M | $78M | · | $108M | $109M | $112M | · | $11M | |
| Total Assets | $924M | $997M | $1.14B | $974M | $1.07B | $1.16B | $1.15B | $1.25B | $1.19B | $1.29B | · | $1.19B | $1.22B | $1.25B | · | $1.39B | |
| Accounts Payable | $34M | $39M | $42M | $42M | $29M | $22M | $18M | $13M | $15M | $16M | · | $17M | $12M | $28M | · | $11M | |
| Accrued Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $21M | |
| Current Liabilities | $198M | $209M | $231M | $235M | $210M | $192M | $226M | $215M | $199M | $204M | · | $200M | $180M | $179M | · | $177M | |
| Capital Leases | · | · | $86M | · | · | · | $99M | · | · | · | · | · | · | · | · | $119M | |
| Other Non-current Liabilities | $124M | $119M | $135M | $152M | $159M | $166M | $157M | $136M | $138M | $140M | · | $145M | $144M | $145M | · | $16M | |
| Total Liabilities | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $695M | |
| Long-term Debt | $101M | $100M | $99M | $98M | $97M | $48M | $48M | $47M | · | · | · | · | · | · | · | · | |
| Common Stock | $2.17B | $2.14B | $2.12B | $1.81B | $1.79B | $1.77B | $1.62B | $1.60B | $1.58B | $1.56B | · | $1.29B | $1.27B | $1.23B | · | $7.0K | |
| Paid-in Capital | · | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $1.18B | |
| Retained Earnings | $-1.70B | $-1.61B | $-1.49B | $-1.38B | $-1.24B | $-1.24B | $-1.13B | $-1.04B | $-946M | $-853M | · | $-768M | $-697M | $-622M | · | $-475M | |
| AOCI | $-1M | $-1M | · | · | · | · | · | $1M | $-1M | $-1M | · | $-3M | $-4M | $-4M | · | $-10M | |
| Stockholders' Equity | $464M | $524M | $631M | $436M | $549M | $531M | $485M | $565M | $635M | $707M | $462M | $520M | $566M | $600M | $657M | $699M | |
| Liabilities + Equity | $924M | $997M | $1.14B | $974M | $1.07B | $1.16B | $1.15B | $1.25B | $1.19B | $1.29B | · | $1.19B | $1.22B | $1.25B | · | $1.39B | |
| Shares Outstanding | 127,000,000 | 125,500,000 | 125,300,000 | 107,100,000 | 106,400,000 | 105,900,000 | 92,200,000 | 91,500,000 | 91,300,000 | 90,900,000 | 75,500,000 | 74,800,000 | 74,500,000 | 73,100,000 | 72,900,000 | 72,352,380 |
Cashflow
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $3M | $2M | $3M | $2M | $2M | $3M | $3M | $2M | $2M | $3M | $3M | $1M | $2M | $2M | $1M | $2M | |
| Stock-based Comp | $15M | $19M | $15M | $14M | $15M | $16M | $17M | $19M | $20M | $20M | $18M | $18M | $18M | $19M | $17M | $16M | |
| Operating Cash Flow | $-119M | $-138M | $-120M | $-97M | $-133M | $-132M | $-100M | $26M | $-94M | $-2M | $-88M | $-63M | $-57M | $-98M | $-70M | $-81M | |
| CapEx | $0 | $0 | $1M | $0 | $0 | $1M | $1M | $1M | $0 | $4M | $6M | $10M | $5M | $3M | $0 | $2M | |
| Investing Cash Flow | $52M | $114M | $-182M | $79M | $137M | $32M | $51M | $-29M | $63M | $-169M | $28M | $11M | $26M | $129M | $47M | $23M | |
| Stock Issued | $0 | $0 | $279M | $8M | $0 | $142M | $0 | $0 | $0 | $228M | $0 | $5M | $20M | $0 | $0 | · | |
| Net Stock Activity | · | $0 | · | · | · | $142M | · | · | · | $228M | · | · | · | · | · | · | |
| Financing Cash Flow | $16M | $3M | $286M | $8M | $52M | $142M | $-2M | $48M | $2M | $229M | $3M | $6M | $23M | $1M | $11M | $3M | |
| Net Change in Cash | $-51M | $-21M | $-16M | $-10M | $56M | $42M | $-51M | $45M | $-29M | $58M | $-57M | $-46M | $-8M | $32M | $-12M | $-55M | |
| Free Cash Flow | · | $-138M | · | · | · | $-133M | · | · | · | $-6M | · | · | · | $-101M | · | · |
Rentabilität
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | -234.1% | -788.2% | · | -546.1% | -5.0% | -435.7% | · | -218.8% | -271.8% | -11.0% | · | -250.0% | -286.2% | -344.0% | · | -206.7% | |
| Net Margin | -221.9% | -752.9% | · | -519.2% | 0.00% | -400.0% | · | -191.7% | -238.5% | -2.8% | · | -221.9% | -258.6% | -320.0% | · | -193.3% | |
| Pretax Margin | -221.9% | -752.9% | · | -519.2% | 0.00% | -400.0% | · | -191.7% | -238.5% | -2.8% | · | -215.6% | -255.2% | -312.0% | · | -193.3% | |
| EBITDA Margin | -234.1% | -788.2% | · | -546.1% | -5.0% | -435.7% | · | -218.8% | -271.8% | -11.0% | · | -250.0% | -286.2% | -344.0% | · | -206.7% | |
| ROA | -9.1% | -11.9% | · | -12.1% | 0.00% | -9.2% | · | -7.5% | -7.7% | -0.31% | · | -5.5% | -5.6% | -5.7% | · | -5.8% | |
| ROE | -18.0% | -24.3% | · | -27.0% | 0.00% | -18.1% | · | -17.0% | -15.5% | -0.61% | · | -11.7% | -11.4% | -11.5% | · | -10.5% | |
| ROIC | -20.7% | -25.6% | · | -32.6% | · | -23.0% | · | -18.6% | -16.7% | -2.3% | · | -15.8% | -14.9% | -14.7% | · | -9.9% |
Liquidität & Solvenz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 3.8 | 4.0 | · | 3.6 | 4.5 | 5.4 | · | 5.2 | 5.1 | 5.2 | · | 4.4 | 5.5 | 5.7 | · | 6.2 | |
| Quick Ratio | 0.8 | 1.0 | · | 1.0 | 1.2 | 1.0 | · | 0.9 | 0.8 | 0.9 | · | 0.9 | 1.3 | 1.3 | · | 1.2 |
Effizienz
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | · | 0.0 | 0.1 | 0.0 | · | 0.0 | 0.0 | 0.1 | · | 0.0 | 0.0 | 0.0 | · | 0.0 |
Pro Aktie
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $3.65 | $4.18 | · | $4.07 | $5.16 | $5.01 | · | $6.17 | $6.96 | $7.78 | · | $6.95 | $7.60 | $8.21 | · | $9.66 | |
| Revenue / Share | $0.33 | $0.14 | · | $0.24 | $1.50 | $0.28 | · | $0.53 | $0.43 | $1.68 | · | $0.43 | $0.40 | $0.34 | · | $0.46 | |
| Cash Flow / Share | · | $-1.10 | · | · | · | $-1.34 | · | · | · | $-0.02 | · | · | · | $-1.34 | · | · | |
| Cash / Share | $1.18 | $1.60 | · | $2.22 | $2.33 | $1.81 | · | $2.20 | $1.71 | $2.04 | · | $2.46 | $3.09 | $3.26 | · | $3.01 | |
| EPS (TTM) | $-3.89 | $-3.17 | · | $-3.48 | $-3.21 | $-4.23 | · | $-3.15 | $-3.09 | $-3.11 | · | $-4.00 | $-3.96 | · | · | · |
Bewertung (TTM)
| Kennzahl | Trend | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $117M | $236M | · | $240M | $262M | $141M | · | $263M | $247M | $237M | · | $120M | $121M | $119M | · | $433M | |
| Net Income TTM | $-460M | $-369M | · | $-341M | $-298M | $-391M | · | $-270M | $-249M | $-231M | · | $-293M | $-287M | $-279M | · | $80M | |
| Market Cap | $3.92B | $2.71B | · | $1.46B | $866M | $831M | · | $1.40B | $1.39B | $1.72B | · | $1.34B | $1.51B | $1.33B | · | $1.89B | |
| P/E | -7.9 | -6.8 | · | -3.9 | -2.5 | -1.9 | · | -4.9 | -4.9 | -6.1 | · | -4.5 | -5.1 | · | · | · | |
| P/S | 33.5 | 11.5 | · | 6.1 | 3.3 | 5.9 | · | 5.3 | 5.6 | 7.2 | · | 11.2 | 12.5 | 11.2 | · | 4.4 | |
| P/B | 8.4 | 5.2 | · | 3.3 | 1.6 | 1.6 | · | 2.5 | 2.2 | 2.4 | · | 2.6 | 2.7 | 2.2 | · | 2.7 | |
| P / Tangible Book | 8.4 | 5.2 | · | 3.3 | 1.6 | 1.6 | · | 2.5 | 2.2 | 2.4 | · | 2.6 | 2.7 | 2.2 | · | 2.7 | |
| P / Cash Flow | · | -19.6 | · | · | · | -6.3 | · | · | · | -858.1 | · | · | · | -13.6 | · | · | |
| Earnings Yield | -12.6% | -14.7% | · | -25.6% | -39.4% | -53.9% | · | -20.6% | -20.3% | -16.5% | · | -22.3% | -19.5% | · | · | · |
Aktuellster Zeitraum links · fehlende Werte werden als · angezeigt
Finanzberichte Gewinn- und Verlustrechnung, Bilanz, Cashflow — jährlich, letzte 5 Jahre
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Umsatz | $247M | $258M | $117M | $112M | $383M |
| Betriebsgewinnmarge % | -156.3% | -127.9% | -290.6% | -250.0% | 14.2% |
| Nettoergebnis | $-353M | $-283M | $-307M | $-267M | $53M |
| Verwässerte EPS | $-3.29 | $-3.14 | $-4.15 | $-3.71 | $0.71 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Liquiditätsgrad | 4.4 | 4.5 | 4.5 | 5.5 | 7.6 |
| Quick Ratio | 1.0 | 0.7 | 0.7 | 1.1 | 0.9 |
| Kennzahl | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Freier Cashflow | $-484M | $-176M | $-330M | $432M | $-282M |
Institutionelle Eigentümer (13F) 243 Einreicher · $4.0B gesamt · Stand 30. September 2026
Institutionen, die diese Aktie in ihrer vierteljährlichen SEC-Formular 13F melden. Nur Long-Positionen; ein einzelner Einreicher kann für separate Optionsscheine zweimal erscheinen. Große gegenläufige Put/Call-Positionen spiegeln typischerweise Market-Making oder abgesicherte Bestände wider, nicht die gerichtete Überzeugung.
Inhaber
243
Gehaltener Wert
$4.0B
Neue Positionen
46
Geschlossene Positionen
23
Institutionelle Aktivität — Q2 2026 vs. Vorquartal
| Neue Positionen | Geschlossene Positionen | Erhöht | Abgenommen | Nettoveränderung der Aktien |
|---|---|---|---|---|
| 46 (+5 vs. Vorquartal) | 23 (-8 vs. Vorquartal) | 86 (+2 vs. Vorquartal) | 64 (+4 vs. Vorquartal) | +4.3M |
Verglichen mit Q1 2026. SEC-Formular 13F-Einreichungen sind innerhalb von 45 Tagen nach Quartalsende fällig, zuzüglich einer kurzen Pufferzeit für verspätete Einreicher — Quartale, die noch in diesem Fenster liegen, werden zugunsten des letzten vollständig berichteten Paares übersprungen.
| Institution | Wert | Aktien | % der verfolgten 13F | Typ |
|---|---|---|---|---|
| GILEAD SCIENCES, INC. | $968.825.351 | 31.424.760 | 24,50% | Aktien |
| BlackRock, Inc. | $506.112.958 | 16.416.249 | 12,80% | Aktien |
| VANGUARD GROUP INC | $189.755.288 | 7.962.874 | 4,80% | Aktien |
| STATE STREET CORP | $185.888.992 | 6.029.484 | 4,70% | Aktien |
| WELLINGTON MANAGEMENT GROUP LLP | $181.756.661 | 5.895.448 | 4,60% | Aktien |
| MONTANOVA CAPITAL, LLC | $147.257.121 | 4.776.423 | 3,72% | Aktien |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $137.980.528 | 4.475.528 | 3,49% | Aktien |
| FMR LLC | $124.854.021 | 4.049.757 | 3,16% | Aktien |
| VANGUARD CAPITAL MANAGEMENT LLC | $119.877.707 | 3.888.346 | 3,03% | Aktien |
| CITADEL ADVISORS LLC | $96.653.807 | 3.135.057 | 2,44% | Aktien |
| Woodline Partners LP | $92.730.412 | 3.007.798 | 2,35% | Aktien |
| GEODE CAPITAL MANAGEMENT, LLC | $75.507.790 | 2.448.749 | 1,91% | Aktien |
| Siren, L.L.C. | $74.621.857 | 2.420.430 | 1,89% | Aktien |
| Fisher Asset Management, LLC | $65.957.578 | 2.139.396 | 1,67% | Aktien |
| MARSHALL WACE, LLP | $59.967.064 | 1.945.088 | 1,52% | Aktien |
| SAMLYN CAPITAL, LLC | $47.699.621 | 1.547.182 | 1,21% | Aktien |
| DIMENSIONAL FUND ADVISORS LP | $44.221.943 | 1.434.320 | 1,12% | Aktien |
| BNP PARIBAS ASSET MANAGEMENT Holding S.A. | $43.764.202 | 1.419.533 | 1,11% | Aktien |
| GOLDMAN SACHS GROUP INC | $42.778.660 | 1.387.566 | 1,08% | Aktien |
| Soleus Capital Management, L.P. | $36.032.193 | 1.168.738 | 0,91% | Aktien |
| Sofinnova Investments, Inc. | $29.155.623 | 945.690 | 0,74% | Aktien |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | $29.034.337 | 941.756 | 0,73% | Aktien |
| NORTHERN TRUST CORP | $28.749.685 | 932.523 | 0,73% | Aktien |
| Parkman Healthcare Partners LLC | $28.340.971 | 919.266 | 0,72% | Aktien |
| Invesco Ltd. | $26.058.533 | 845.233 | 0,66% | Aktien |
| BAKER BROS. ADVISORS LP | $26.045.677 | 844.816 | 0,66% | Aktien |
| BANK OF AMERICA CORP /DE/ | $25.758.589 | 835.504 | 0,65% | Aktien |
| MORGAN STANLEY | $24.537.986 | 795.912 | 0,62% | Aktien |
| Candriam S.C.A. | $20.389.238 | 661.981 | 0,52% | Aktien |
| Aberdeen Group plc | $20.061.451 | 650.712 | 0,51% | Aktien |
| Logos Global Management LP | $20.039.500 | 650.000 | 0,51% | Aktien |
| TWO SIGMA INVESTMENTS, LP | $19.589.505 | 635.404 | 0,50% | Aktien |
| VANGUARD FIDUCIARY TRUST CO | $18.993.993 | 616.088 | 0,48% | Aktien |
| Bank of New York Mellon Corp | $16.740.979 | 543.009 | 0,42% | Aktien |
| JACOBS LEVY EQUITY MANAGEMENT, INC | $15.787.550 | 512.084 | 0,40% | Aktien |
| Ikarian Capital, LLC | $15.555.555 | 504.559 | 0,39% | Aktien |
| Decheng Capital LLC | $14.329.137 | 464.779 | 0,36% | Aktien |
| DAFNA Capital Management LLC | $13.621.588 | 441.829 | 0,34% | Aktien |
| JPMORGAN CHASE & CO | $13.121.105 | 418.243 | 0,33% | Aktien |
| PRINCIPAL FINANCIAL GROUP INC | $13.052.373 | 423.366 | 0,33% | Aktien |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | $11.688.000 | 379.100 | 0,30% | Aktien |
| UBS Group AG | $11.377.996 | 369.056 | 0,29% | Aktien |
| Patient Square Capital LP | $10.969.314 | 355.800 | 0,28% | Aktien |
| PDT Partners, LLC | $9.975.571 | 323.567 | 0,25% | Aktien |
| Public Sector Pension Investment Board | $9.192.149 | 298.156 | 0,23% | Aktien |
| FIRST TRUST ADVISORS LP | $8.368.310 | 271.434 | 0,21% | Aktien |
| Nuveen, LLC | $7.215.824 | 234.052 | 0,18% | Aktien |
| Connor, Clark & Lunn Investment Management Ltd. | $6.936.997 | 225.008 | 0,18% | Aktien |
| DIADEMA PARTNERS LP | $6.900.062 | 223.810 | 0,17% | Aktien |
| RHUMBLINE ADVISERS | $6.757.319 | 219.181 | 0,17% | Aktien |
Aktivisten & 5%+-Eigentümer 3 Beteiligungen
Investoren mit SEC Schedule 13D — wirtschaftliches Eigentum über 5% mit der Absicht, Einfluss auf den Emittenten zu nehmen (aktivistische Beteiligungen, Board-Kampagnen, M&A). Jede Zeile zeigt den zuletzt bekannten Stand der Position dieses Melders.
| Anmelder | Eingereicht | Beteiligung | Status | Zweck | Einreichung |
|---|---|---|---|---|---|
| Gilead Sciences, Inc. | 7. August 2026 | 24,70% | Änderung | · | SEC |
| Terry Rosen, Ph.D. ×2 Einreichungen | 17. Dezember 2024 | · | Erste Einreichung | · | SEC |
| Juan Jaen, Ph.D., Anita Galeana, Juan Carlos Jaen and Anita Galeana 2000 Trust ×2 Einreichungen | 15. Oktober 2020 | · | Erste Einreichung | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Unternehmensinsider 23 Insider · 12 Führungskräfte · 10 Direktoren
| Insider | Rolle | Letzte Aktivität | Gehaltene Aktien | Käufe 12m | Verkäufe 12m | Netto 12m |
|---|---|---|---|---|---|---|
| Terry J Rosen | Chief Executive Officer | 23. Januar 2026 A | 2.236.409 | 0 | 2 | $-1.203.847 |
| Ii Robert C. Goeltz | Chief Financial Officer | 11. Mai 2026 S | 84.161 | 0 | 6 | $-855.866 |
| Rekha Hemrajani | Chief Operating Officer and Chief Financial Officer | 25. März 2019 A | · | 0 | 0 | $0 |
| Juan C. Jaen | President | 10. Juli 2026 S | 822.240 | 0 | 21 | $-9.219.575 |
| Jennifer Jarrett | Chief Operating Officer | 23. Januar 2026 A | 224.024 | 0 | 5 | $-2.171.366 |
| Alexander Azoy | Chief Accounting Officer | 21. August 2026 M | 39.581 | 0 | 6 | $-395.676 |
| Carolyn C. Tang | General Counsel | 11. Juni 2026 M | 184.607 | 0 | 2 | $-318.467 |
| Richard Markus | Chief Medical Officer | 23. Januar 2026 A | 89.647 | 0 | 2 | $-210.125 |
| Nuyten Dimitry SA | Chief Medical Officer | 15. Dezember 2024 F | 87.518 | 0 | 0 | $0 |
| William Grossman | Chief Medical Officer | 17. Juni 2021 S | 20.723 | 0 | 0 | $0 |
| Jason Barker | VP Finance; Principal Financial and Accounting Officer | 4. Juni 2020 A | 10.000 | 0 | 0 | $0 |
| Steven Chan | Principal Financial and Accounting Officer | 16. Januar 2019 A | · | 0 | 0 | $0 |
| Antoni Ribas | Direktor | 11. Juni 2026 A | 44.300 | 0 | 0 | $0 |
| Nicole Lambert | Direktor | 11. Juni 2026 A | 43.000 | 0 | 0 | $0 |
| David L. Lacey | Direktor | 11. Juni 2026 A | 76.652 | 0 | 0 | $0 |
| Patrick Machado | Direktor | 11. Juni 2026 A | 44.300 | 0 | 0 | $0 |
| Yasunori Kaneko | Direktor | 11. Juni 2026 A | 25.700 | 0 | 0 | $0 |
| Kathryn E Falberg | Direktor | 11. Juni 2026 A | 44.300 | 0 | 0 | $0 |
| Andrew J Perlman | Direktor | 11. Juni 2026 A | 48.325 | 0 | 0 | $0 |
| Kristen Hege | Direktor | 6. Juni 2019 A | · | 0 | 0 | $0 |
| David W Beier | Direktor | 6. Juni 2019 A | · | 0 | 0 | $0 |
| Gilead Sciences, Inc. | 10%-Eigentümer | 18. Februar 2025 P | 31.424.760 | 0 | 0 | $0 |
| Hadley Harbor Master Investors (Cayman) II L.P. | 10%-Eigentümer | 19. März 2018 C | 1.496.813 | 0 | 0 | $0 |
Insider aus SEC-Einreichungen Form 3/4/5; Netto = nur P/S aus offenen Märkten
ETF-Besitz Gehalten von 56 ETFs
Gewichtung spiegelt nur direkte Aktienbestände (N-PORT) wider; gehebelte oder derivatbasierte Fonds können zusätzliche Swap-Exposure halten, die hier nicht angezeigt wird.
| Fonds | Gewicht | Anteile | Stand | Quelle |
|---|---|---|---|---|
| IDNA · iShares Trust | 2,13% | 207.943 SH | 11. September 2026 | Täglich |
| PSCH · Invesco Exchange-Traded Fund Trust … | 1,26% | 86.868 SH | 1. Oktober 2026 | Täglich |
| BBC · ETFis Series Trust I | 0,79% | 13.060 NS | 31. Juli 2026 | N-PORT |
| XSMO · Invesco Exchange-Traded Fund Trust | 0,78% | 864.538 SH | 1. Oktober 2026 | Täglich |
| FYC · First Trust Exchange-Traded AlphaDE… | 0,62% | 284.644 NS | 31. Juli 2026 | N-PORT |
| LABU · Direxion Shares ETF Trust | 0,50% | 87.676 NS | 31. Juli 2026 | N-PORT |
| DWAS · Invesco Exchange-Traded Fund Trust … | 0,44% | 69.039 SH | 1. Oktober 2026 | Täglich |
| JDOC · J.P. Morgan Exchange-Traded Fund Tr… | 0,43% | 1.384 NS | 31. Juli 2026 | N-PORT |
| FYX · First Trust Exchange-Traded AlphaDE… | 0,23% | 113.180 NS | 31. Juli 2026 | N-PORT |
| VFMO · VANGUARD WELLINGTON FUND | 0,19% | 121.164 SH | 19. August 2026 | Täglich |
| VIOG · VANGUARD ADMIRAL FUNDS | 0,18% | 65.077 SH | 19. August 2026 | Täglich |
| IBB · iShares Trust | 0,16% | 639.708 SH | 11. September 2026 | Täglich |
| QVMS · Invesco Exchange-Traded Fund Trust … | 0,15% | 13.473 SH | 1. Oktober 2026 | Täglich |
| PWS · Pacer Funds Trust | 0,14% | 1.198 NS | 31. Juli 2026 | N-PORT |
| VIOO · VANGUARD ADMIRAL FUNDS | 0,14% | 303.431 SH | 19. August 2026 | Täglich |
| VTWG · VANGUARD SCOTTSDALE FUNDS | 0,13% | 75.323 SH | 19. August 2026 | Täglich |
| FAD · First Trust Exchange-Traded AlphaDE… | 0,13% | 25.784 NS | 31. Juli 2026 | N-PORT |
| IWO · iShares Trust | 0,12% | 658.371 SH | 11. September 2026 | Täglich |
| VIOV · VANGUARD ADMIRAL FUNDS | 0,11% | 68.135 SH | 19. August 2026 | Täglich |
| BKSE · BNY Mellon ETF Trust | 0,11% | 3.277 NS | 31. Juli 2026 | N-PORT |
| BBSC · J.P. Morgan Exchange-Traded Fund Tr… | 0,09% | 22.969 NS | 31. Juli 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,09% | 90.886 SH | 1. Oktober 2026 | Täglich |
| RSSL · Global X Funds | 0,08% | 42.828 NS | 31. Juli 2026 | N-PORT |
| VTWO · VANGUARD SCOTTSDALE FUNDS | 0,08% | 514.877 SH | 19. August 2026 | Täglich |
| IWM · iShares Trust | 0,08% | 2.296.266 SH | 11. September 2026 | Täglich |
| ESML · iShares Trust | 0,06% | 61.466 SH | 11. September 2026 | Täglich |
| DFAS · Dimensional ETF Trust | 0,05% | 273.376 NS | 31. Juli 2026 | N-PORT |
| TECB · iShares Trust | 0,04% | 8.223 SH | 11. September 2026 | Täglich |
| SMDX · Tidal Trust III | 0,04% | 1.986 NS | 31. Juli 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,04% | 586.542 SH | 19. August 2026 | Täglich |
| VTWV · VANGUARD SCOTTSDALE FUNDS | 0,04% | 16.721 SH | 19. August 2026 | Täglich |
| VHT · VANGUARD WORLD FUND | 0,04% | 264.113 SH | 19. August 2026 | Täglich |
| FHLC · FIDELITY COVINGTON TRUST | 0,04% | 41.576 NS | 31. Juli 2026 | N-PORT |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1.000.271 SH | 19. August 2026 | Täglich |
| ISCG · iShares Trust | 0,03% | 10.730 SH | 11. September 2026 | Täglich |
| VB · VANGUARD INDEX FUNDS | 0,02% | 1.011.587 SH | 19. August 2026 | Täglich |
| WSML · iShares Trust | 0,02% | 5.013 SH | 11. September 2026 | Täglich |
| TILT · FlexShares Trust | 0,01% | 6.162 NS | 31. Juli 2026 | N-PORT |
| RWJ · Invesco Exchange-Traded Fund Trust … | 0,01% | 5.338 SH | 1. Oktober 2026 | Täglich |
| ITOT · iShares Trust | 0,00% | 124.162 SH | 11. September 2026 | Täglich |
| DCOR · Dimensional ETF Trust | 0,00% | 3.906 NS | 31. Juli 2026 | N-PORT |
| DFAU · Dimensional ETF Trust | 0,00% | 12.625 NS | 31. Juli 2026 | N-PORT |
| IWV · iShares Trust | 0,00% | 21.339 SH | 11. September 2026 | Täglich |
| DFAC · Dimensional ETF Trust | 0,00% | 11.946 NS | 31. Juli 2026 | N-PORT |
| DFUS · Dimensional ETF Trust | 0,00% | 2.340 NS | 31. Juli 2026 | N-PORT |
| VTI · VANGUARD INDEX FUNDS | 0,00% | 2.799.235 SH | 19. August 2026 | Täglich |
| VTHR · VANGUARD SCOTTSDALE FUNDS | 0,00% | 7.495 SH | 19. August 2026 | Täglich |
| IJR · iShares Trust | · | 5.294.319 SH | 10. September 2026 | Täglich |
| IJT · iShares Trust | · | 517.549 SH | 9. September 2026 | Täglich |
| IJS · iShares Trust | · | 287.856 SH | 8. September 2026 | Täglich |
| IWN · iShares Trust | · | 185.987 SH | 11. September 2026 | Täglich |
| XJR · iShares Trust | · | 11.976 SH | 31. August 2026 | Täglich |
| ISCB · iShares Trust | · | 3.839 SH | 11. September 2026 | Täglich |
| ISCV · iShares Trust | · | 11.367 SH | 11. September 2026 | Täglich |
| SMLF · iShares Trust | · | 99.950 SH | 11. September 2026 | Täglich |
| SMMV · iShares Trust | · | 4.789 SH | 1. September 2026 | Täglich |
RCUS Analysten-Konsens Bullische und bärische Analystenmeinungen, 12-Monats-Kursziel, Aufwärtspotenzial
Bewertung · 19 Analysten
KAUF
Median-Ziel
$43.00
+75,9%
5 26,3%
Starker Kauf
10 52,6%
Kauf
4 21,1%
Halten
0 0,0%
Verkauf
0 0,0%
Starker Verkauf
12-Monats-Kursziel
11 Analysten · 2026-09-30Mittelwert-Ziel $39.91 +63,3%
Jetzt
Aktueller Preis $24.44
Tief$23.00
Mittelwert$39.91
Hoch$47.00
Peer-Vergleich (GICS-Subbranche) Wichtige Kennzahlen im Vergleich zu Branchenkollegen
FY-Basis, Kurse zum Schlusskurs am Ende des letzten Geschäftsjahres jedes Unternehmens.
| Ticker | Marktkapitalisierung | P/E | Umsatz Vj. | Nettomarge | ROE | Bruttogewinnmarge |
|---|---|---|---|---|---|---|
| RCUS | $2.99B | -7.2 | -4.3% | -142.9% | -59.8% | · |
| CELC | $4.81B | -26.3 | · | · | -244.3% | · |
| CDNA | $959M | -47.1 | 13.8% | -5.6% | -6.8% | · |
| ACAD | $4.55B | 11.6 | 11.9% | 36.5% | 38.1% | · |
| DNLI | $2.58B | -5.6 | 204.7% | · | -50.2% | · |
| ARQT | $3.58B | -223.4 | 91.3% | -4.3% | -9.8% | · |
| PGEN | $1.48B | -3.1 | 146.7% | -2588.2% | 3159.1% | · |
| DYN | $3.23B | -5.6 | · | · | -57.8% | · |
| PURR | $1.58B | 2.5 | · | 3229.8% | 24.8% | · |
| BEAM | $2.82B | -34.2 | 120.0% | -57.2% | -7.0% | · |
Meine Kennzahlen Ihre persönliche Watchlist — ausgewählte Zeilen aus den vollständigen Fundamentaldaten
Wählen Sie die Kennzahlen, die für Sie wichtig sind — klicken Sie auf das + neben jeder Zeile in den vollständigen Fundamentaldaten oben.
Ihre Auswahl wird gespeichert und begleitet Sie über alle Ticker hinweg.
Quelle: SEC 10-Q eingereicht Aug 5, 2026